RENAL CARE GROUP INC
424B3, 1999-11-12
MISC HEALTH & ALLIED SERVICES, NEC
Previous: LEARN2 COM INC, 8-K, 1999-11-12
Next: LABORATORY CORP OF AMERICA HOLDINGS, 10-Q, 1999-11-12



<PAGE>   1
                                                                  Filed pursuant
                                                               to Rule 424(b)(3)
                                                              File No. 333-77533
                                                          Renal Care Group, Inc.


            PROSPECTUS SUPPLEMENT NO. 4, DATED NOVEMBER 11, 1999, TO
                         PROSPECTUS DATED JUNE 24, 1999


         In order to reflect the transfer of Common Stock from FLM Partners to
its three partners MacNeal Management Services, Inc., Laurens Lohmann, M.D. and
Kenneth Fisher, M.D., the table of Selling Shareholders in the Selling
Shareholders' section of the Prospectus is revised and supplemented as follows:

<TABLE>
<CAPTION>
                                        Shares Beneficially                               Shares
                                            Owned Before           Shares Being        Beneficially
                                            the Offering             Offered          Owned After the
           Name                                                                          Offering
<S>                                     <C>                        <C>                <C>
MacNeal Management Services, Inc.               17,411                9,060              9,052(2)
Laurens Lohmann, M.D.                           10,449                5,437              5,433(2)
Kenneth Fisher, M.D.                             9,673                5,034              5,028(2)
</TABLE>


(2) The shares owned beneficially after the offering includes shares received by
FLM Partners after the initiation of the offering and which were subsequently
transferred to its three partners in the following amounts: 701 to MacNeal
Management Services, Inc., 421 to Laurens Lohmann, M.D. and 389 to Kenneth
Fisher, M.D.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission